This leads to a reduction in ovarian reserve and a higher occurrence of chromosomal abnormalities especially aneuploidy in oocytes 3,4 , increasing the risks of infertility, pregnancy loss, perinatal mortality, and congenital disorders in women at an advanced age 5,6
Adding AOD 9604 targeted fat breakdown may shift this ratio even further toward preferential fat loss, though controlled studies of the combination are limited
This is not the best way
Scientific Literature Note Research interest data is provided for scientific reference purposes only, based on published preclinical or in vitro literature
Kompatibilitt: Gleichzeitige Verwendung in derselben Formel mit starken Chelatbildnern, Suren, Allantoin, Niacinamid, Arbutin und Carbomer vermeiden